Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | M01AX17 |
UNII: | V4TKW1454M |
InChI Key | HYWYRSMBCFDLJT-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C13H12N2O5S |
Molecular Weight | 308.31 |
AlogP | 2.76 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 98.54 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 21.0 |
Primary Target | |
---|---|
COX-1 | |
COX-2 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 19
Cytochrome P450 family 19A
Cytochrome P450 19A1
|
- | 27000 | - | - | - | |
Enzyme
Hydrolase
|
- | - | - | 70000 | - | |
Enzyme
Oxidoreductase
|
- | 15-23140 | - | - | 7-100 | |
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4B
|
- | - | - | - | 52 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 58 | |
Transporter
Primary active transporter
Oxidoreduction-driven transporters
|
- | - | - | - | 90-90 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Pain | 1 | D010146 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 51803-78-2 |
ChEBI | 44445 |
ChEMBL | CHEMBL56367 |
DrugBank | DB04743 |
DrugCentral | 1935 |
EPA CompTox | DTXSID3037250 |
FDA SRS | V4TKW1454M |
Guide to Pharmacology | 7401 |
PDB | NIM |
PharmGKB | PA137179528 |
PubChem | 4495 |
SureChEMBL | SCHEMBL24882 |
ZINC | ZINC000004617749 |